Phage Engineering for Targeted Multidrug-Resistant Escherichia coli. 2023

Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Jinan 250000, China.

The lytic bacteriophages have potential application value in the treatment of bacterial infections. However, the narrow host spectrum of these phages limits their range of clinical application. Here, we demonstrate the use of scarless Cas9-assisted recombination (no-SCAR) gene-editing technology to regulate phage-host range. We used phage PHB20 as the scaffold to create agents targeting different multidrug-resistant Escherichia coli by replacing its phage tail fiber gene (ORF40). The engineered phages were polyvalent and capable of infecting both the original host bacteria and new targets. Phage-tail fiber genes can be amplified by PCR to construct a recombinant phage PHB20 library that can deal with multidrug-resistant bacteria in the future. Our results provide a better understanding of phage-host interactions, and we describe new anti-bacterial editing methods.

UI MeSH Term Description Entries
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000072669 Gene Editing Genetic engineering or molecular biology techniques that involve DNA REPAIR mechanisms for incorporating site-specific modifications into a cell's genome. Base Editing,Genome Editing,Editing, Base,Editing, Gene,Editing, Genome
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001435 Bacteriophages Viruses whose hosts are bacterial cells. Phages,Bacteriophage,Phage
D024901 Drug Resistance, Multiple, Bacterial The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Drug Resistance, Extensive, Bacterial,Drug Resistance, Extensively, Bacterial,Extensive Antibacterial Drug Resistance,Extensively Antibacterial Drug Resistance,Multidrug Resistance, Bacterial,Multiple Antibacterial Drug Resistance,Bacterial Multidrug Resistance,Bacterial Multidrug Resistances,Resistance, Bacterial Multidrug

Related Publications

Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
December 2019, Scientific reports,
Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
January 2020, Ophthalmic plastic and reconstructive surgery,
Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
October 2013, Emerging infectious diseases,
Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
May 2023, Journal of microbiology (Seoul, Korea),
Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
January 2018, Frontiers in microbiology,
Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
January 2023, Frontiers in cellular and infection microbiology,
Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
January 2022, Virus research,
Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
August 2022, Nature communications,
Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
April 1960, Journal of bacteriology,
Jiaoyang Song, and Zhengjie Liu, and Qing Zhang, and Yuqing Liu, and Yibao Chen
February 2022, World journal of microbiology & biotechnology,
Copied contents to your clipboard!